McCall and colleagues, in a study involving 297 patients with pancreatic neuroendocrine tumors, found that grading using both the Ki-67 index and mitotic count increases prognostic accuracy compared to either parameter alone [7]. The gene discussed is MKI67; the disease is pancreatic neuroendocrine tumor.